Hana Dostálová

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Cell Cycle Arrest

Chronic Myeloid Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Thalia Delgado, Denisa Veselá, Hana Dostálová, Vladimir Kryštof, Veronika Vojáčková, Radek Jorda, Alejandro Castro-Alvarez, Jeanluc Bertrand, Gildardo Rivera, Mario Faúndez, Miroslav Strnad, Christian Espinosa-Bustos, Cristian O Salas
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics 16 (5) (2024)
Thalia Delgado, Denisa Veselá, Hana Dostálová, Vladimir Kryštof, Veronika Vojáčková, Radek Jorda, Alejandro Castro-Alvarez, Jeanluc Bertrand, Gildardo Rivera, Mario Faúndez, Miroslav Strnad, Christian Espinosa-Bustos, Cristian O Salas
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs. Pharmaceutics 16 (5) (2024)
Jeanluc Bertrand, Hana Dostálová, Vladimir Kryštof, Radek Jorda, Thalía Delgado, Alejandro Castro-Alvarez, Jaime Mella-Raipán, David Cabezas, Mario Faúndez, Christian Espinosa-Bustos, Cristian O Salas
Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia. Pharmaceutics 14 (6) (2022)